Pharmaceutical Executive November 11, 2024
The latest news for pharma industry insiders.
Peer Exchange: The Importance of Improving DE&I in Clinical Trials
In this roundtable discussion, industry experts gathered to address the state of achieving greater diversity in clinical research. The group highlighted a variety of topics including current challenges they are seeing, the use of technology, and more.
Moderated by Otis Johnson, PhD, MPA Co-Founder & Principal Consultant, Trial Equity, the panel featured key insights from Sophia McLeod, Sr. Director, Government Relations, ACRO; Erin Stern, PharmD, Research Support Pharmacist, Mayo Clinic; and Caitlin Brown, PharmD, Neurocritical Care and Emergency Medicine Clinical Pharmacist, Mayo Clinic.
Why Financial Toxicity is About More Than Just Affording Treatment
The idea of financial toxicity combines the physical stress of...
Today's Sponsors
Today's Sponsor